These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 31492588)
1. Expression and clinical significance of CPS1 in glioblastoma multiforme. Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588 [TBL] [Abstract][Full Text] [Related]
2. Owusu-Ansah M; Guptan N; Alindogan D; Morizono M; Caldovic L Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047726 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma. Liu H; Dong H; Robertson K; Liu C Am J Pathol; 2011 Feb; 178(2):652-61. PubMed ID: 21281797 [TBL] [Abstract][Full Text] [Related]
4. Wu G; Zhao Z; Yan Y; Zhou Y; Wei J; Chen X; Lin W; Ou C; Li J; Wang X; Xiong K; Zhou J; Xu Z Ann Transl Med; 2020 Mar; 8(6):341. PubMed ID: 32355785 [TBL] [Abstract][Full Text] [Related]
5. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma. Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451 [TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma. Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808 [TBL] [Abstract][Full Text] [Related]
7. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis. Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme. Han J; Puri RK J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083 [TBL] [Abstract][Full Text] [Related]
9. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis. Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116 [TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma. Wang S; Liu F; Wang Y; Fan W; Zhao H; Liu L; Cen C; Jiang X; Sun M; Han P J Transl Med; 2019 May; 17(1):179. PubMed ID: 31138312 [TBL] [Abstract][Full Text] [Related]
11. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
12. Identification of Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702 [No Abstract] [Full Text] [Related]
13. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells. Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507 [TBL] [Abstract][Full Text] [Related]
14. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology. Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447 [TBL] [Abstract][Full Text] [Related]
15. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma. Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888 [TBL] [Abstract][Full Text] [Related]
16. Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis. Yang Y; Chu L; Zeng Z; Xu S; Yang H; Zhang X; Jia J; Long N; Hu Y; Liu J Bioengineered; 2021 Dec; 12(1):6643-6654. PubMed ID: 34516348 [TBL] [Abstract][Full Text] [Related]
17. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer. Fatai AA; Gamieldien J BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978 [TBL] [Abstract][Full Text] [Related]
18. Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma. Wen WS; Hu SL; Ai Z; Mou L; Lu JM; Li S J Cell Physiol; 2017 Dec; 232(12):3622-3630. PubMed ID: 28145562 [TBL] [Abstract][Full Text] [Related]
19. EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma. Chen J; Zhang J; Hong L; Zhou Y Cancer Biomark; 2019; 24(3):343-350. PubMed ID: 30829611 [TBL] [Abstract][Full Text] [Related]
20. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]